Metformin efficacy may also be affected by genetic polymorphisms in OCT1 and 2 transporters and, as a result, patients with Type II Diabetes Mellitus (T2DM) may fail to establish adequate glycemic control [52]. This evidence concerns the gene SLC22A1 and type 2 diabetes mellitus.